Smart home tech could ease COPD care
NCT ID NCT06601777
First seen Jul 07, 2026 · Last updated Jul 14, 2026 · Updated 3 times
Summary
This study tests a smart hospital system that lets people with chronic obstructive pulmonary disease (COPD) monitor their health at home using medical devices. Participants either start using the system right away or after a 3-month wait. The goal is to see if the system improves breathing symptoms, quality of life, and is safe and cost-effective. The trial involves 196 adults with COPD and follows them for 9 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Smart Homespital system (behavioral intervention with home monitoring and exercise)
- What this could lead to
- If effective, this smart home system could help COPD patients manage their condition from home, reducing hospital visits and improving quality of life.
- What could go wrong
- This is a relatively small trial (196 participants) testing a behavioral intervention, so results may not apply to all COPD patients. The system requires patient engagement and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
196 people
The number who actually took part.
- Started
-
Sep 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients diagnosed with COPD who meet the following pulmonary function test results: 1. Pre FEV1 \< 80% \*\*or\*\* 2. Pre FVC \< 80% \*\*or\*\* 3. DLCO \< 60% Exclusion Criteria: 1. Patients who do not agree to participate in the study. 2. Patients who fail to use the medical device equipment. 3. Patients where tracking during the study period is expected to be impossible. 4. Patients who have difficulty communicating verbally. 5. Patients who are bedridden or unable to exercise at all due to severe cardiorespiratory dysfunction. 6. Patients receiving hospital-centered rehabilitation treatment during the study period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Severance Hospital
Seoul, 03722, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The role of volumetric High-Resolution computed tomography (HRCT) of the chest in the assessment of patients with stable chronic obstructive pulmonary disease (COPD)
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- Fine-Mist inhalers aim to reach deep lungs in COPD
- App alerts COPD patients when their inhalers may be out of date
- Virtual reality may help COPD patients breathe easier during exercise
- Can a new injection help COPD patients cut steroid use?